Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey R Schelling

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Kidney International|August 1, 2009
Tissue transglutaminase inhibition as treatment for diabetic glomerular scarring: it's good to be gluelessJeffrey R Schelling
Pediatric Nephrology (Berlin, Germany)|July 26, 2015
Tubular atrophy in the pathogenesis of chronic kidney disease progressionJeffrey R Schelling
Cells|October 27, 2022
The Contribution of Lipotoxicity to Diabetic Kidney DiseaseJeffrey R Schelling
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2005
Diabetes and the kidneyAndrew S O'Connor, Jeffrey R Schelling
Journal of the American Society of Nephrology : JASN|June 10, 2005
Association of metabolic syndrome in nondiabetic patients with increased risk for chronic kidney disease: the fat lady singsJohn R Sedor, Jeffrey R Schelling
Circulation. Cardiovascular Genetics|June 17, 2010
Albuminuria risk in Hispanic populations: not so black and whitePaul E Drawz, Jeffrey R Schelling
Journal of the American Society of Nephrology : JASN|October 27, 2004
The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance?Jeffrey R Schelling, John R Sedor
American Journal of Physiology. Renal Physiology|May 16, 2008
Regulation of cell survival by Na+/H+ exchanger-1Jeffrey R Schelling, Bassam G Abu Jawdeh
Current Opinion in Nephrology and Hypertension|January 9, 2024
Chronic kidney disease associated cardiomyopathy: recent advances and future perspectivesMirela A Dobre, Shruti Ahlawat, Jeffrey R Schelling
Kidney International|February 14, 2002
Approaches to understanding susceptibility to nephropathy: from genetics to genomicsSudha K Iyengar, Jeffrey R Schelling, John R Sedor
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Kidney International|August 1, 2009
Tissue transglutaminase inhibition as treatment for diabetic glomerular scarring: it's good to be gluelessJeffrey R Schelling
Pediatric Nephrology (Berlin, Germany)|July 26, 2015
Tubular atrophy in the pathogenesis of chronic kidney disease progressionJeffrey R Schelling
Cells|October 27, 2022
The Contribution of Lipotoxicity to Diabetic Kidney DiseaseJeffrey R Schelling
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2005
Diabetes and the kidneyAndrew S O'Connor, Jeffrey R Schelling
Journal of the American Society of Nephrology : JASN|June 10, 2005
Association of metabolic syndrome in nondiabetic patients with increased risk for chronic kidney disease: the fat lady singsJohn R Sedor, Jeffrey R Schelling
Circulation. Cardiovascular Genetics|June 17, 2010
Albuminuria risk in Hispanic populations: not so black and whitePaul E Drawz, Jeffrey R Schelling
Journal of the American Society of Nephrology : JASN|October 27, 2004
The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance?Jeffrey R Schelling, John R Sedor
American Journal of Physiology. Renal Physiology|May 16, 2008
Regulation of cell survival by Na+/H+ exchanger-1Jeffrey R Schelling, Bassam G Abu Jawdeh
Current Opinion in Nephrology and Hypertension|January 9, 2024
Chronic kidney disease associated cardiomyopathy: recent advances and future perspectivesMirela A Dobre, Shruti Ahlawat, Jeffrey R Schelling
Kidney International|February 14, 2002
Approaches to understanding susceptibility to nephropathy: from genetics to genomicsSudha K Iyengar, Jeffrey R Schelling, John R Sedor
Pageof 9